CALL FOR PROPOSALS
2022 HSCI JUNIOR FACULTY PROGRAM

AWARD AMOUNT
$600,000 per year to include three or four subprojects of $150,00-$200,000 for up to three years

DEADLINE FOR APPLICATION
Friday, August 5, 2022

ANTICIPATED AWARD DATE
 Tuesday, November 1, 2022

The Harvard Stem Cell Institute (HSCI) invites applications for a new project to be funded through the Junior Faculty Program. The specific purpose of the 2022 call for funding is to identify an innovative collaborative project by junior faculty. Proposed collaborations can represent either basic, translational, or clinical science, and can span multiple disease areas. This funding is meant to support novel, high-impact, and cross-cutting research that could lead to new treatments and/or fundamentally enhance our understanding of the target disease area(s) and/or organ systems. The collaborative project should include a plan for the regular interaction of group members and coordination of research activities carried out in multiple research laboratories.

HSCI expects to fund one junior faculty project starting in 2022 for a period of up to three years.  Any junior faculty collaboration chosen will be funded at a maximum of $600,000 per year (including 20% indirect costs), and must be comprised of either three or four subprojects; each subproject, led by a junior faculty principal investigator, will be funded at $150,000 – $200,000 (including 20% indirect costs) per year for a period of up to 3 years. The award mechanism will not require subcontracts. Awards will be made directly to each subproject PI at her or his host institution.

The junior faculty collaboration selected for funding is subject to annual review by the HSCI Executive Committee, which is solely responsible for evaluating and approving any request for continuation funding.

Click here to view full details.

If you have any questions about the HSCI Junior Faculty Program applications, please feel free to contact Robert Perez, Grants Officer, at robert_perez@harvard.edu.  

Thank you for your interest in HSCI.